Search research articles
Contact Us
Filters
Showing results (61-70 of 77) with videos related to
Page
of 8
Sort By:
Nitric Oxide : Biology and Chemistry
|
January 12, 2010
Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation
Satyananda Patel, Sachin Kumar, Anupam Jyoti, et al.
Blood Advances
|
September 25, 2024
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial
Marisol Betensky, Maua Mosha, Cristina Tarango, et al.
Kidney International Reports
|
July 18, 2025
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
Narayan Prasad, Jeyakumar Meyyappan, Deependra Kumar Yadav, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 3, 2024
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial
Gary M Woods, Alexandra Miller, Maua Mosha, et al.
BMC Health Services Research
|
November 6, 2023
Vaccination practices of pediatric oncologists from eight states
Karely M van Thiel Berghuijs, Heydon K Kaddas, Echo L Warner, et al.
Cancers
|
February 10, 2024
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Anupam Verma, Yueh-Yun Chi, Jemily Malvar, et al.
Leukemia
|
February 26, 2020
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
Franco Locatelli, James A Whitlock, Christina Peters, et al.
Pediatric Hematology and Oncology
|
April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies
John Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy
Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood Advances
|
October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
Jason N Berman, Anupam Verma, Shelton A Viola, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 77) with videos related to
Sort By:
Page
of 8
Nitric Oxide : Biology and Chemistry
|
January 12, 2010
Nitric oxide donors release extracellular traps from human neutrophils by augmenting free radical generation
Satyananda Patel, Sachin Kumar, Anupam Jyoti, et al.
Blood Advances
|
September 25, 2024
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial
Marisol Betensky, Maua Mosha, Cristina Tarango, et al.
Kidney International Reports
|
July 18, 2025
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post-Kidney Biopsy Bleeding
Narayan Prasad, Jeyakumar Meyyappan, Deependra Kumar Yadav, et al.
Research and Practice in Thrombosis and Haemostasis
|
December 3, 2024
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial
Gary M Woods, Alexandra Miller, Maua Mosha, et al.
BMC Health Services Research
|
November 6, 2023
Vaccination practices of pediatric oncologists from eight states
Karely M van Thiel Berghuijs, Heydon K Kaddas, Echo L Warner, et al.
Cancers
|
February 10, 2024
Nivolumab Plus 5-Azacitidine in Pediatric Relapsed/Refractory Acute Myeloid Leukemia (AML): Phase I/II Trial Results from the Therapeutic Advances in Childhood Leukemia and Lymphoma (TACL) Consortium
Anupam Verma, Yueh-Yun Chi, Jemily Malvar, et al.
Leukemia
|
February 26, 2020
Blinatumomab versus historical standard therapy in pediatric patients with relapsed/refractory Ph-negative B-cell precursor acute lymphoblastic leukemia
Franco Locatelli, James A Whitlock, Christina Peters, et al.
Pediatric Hematology and Oncology
|
April 28, 2020
A phase I study of panobinostat in children with relapsed and refractory hematologic malignancies
John Goldberg, Maria Luisa Sulis, Julia Bender, et al.
Journal for Immunotherapy of Cancer
|
October 26, 2024
<i>CRLF2</i>-rearranged B-cell ALL with extramedullary lineage switch to AML following CD19-targeted therapy
Sara K Silbert, Samantha Scanlon, Hao-Wei Wang, et al.
Blood Advances
|
October 22, 2025
Molecular Risk Markers Define Risk of Relapse in Myeloid Leukemia of Down syndrome Beyond Measurable Residual Disease
Jason N Berman, Anupam Verma, Shelton A Viola, et al.
Page
of 8